Comment on: the influence of the pharmaceutical industry on the off-label use of its medicines
Gebhardt draws attention to an important issue. The responsibility for informing and warning patients about adverse effects and how to prevent them, or …
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
BMJ Publ.
2002
|
In: |
Journal of medical ethics
Year: 2002, Volume: 28, Issue: 4, Pages: 277 |
Online Access: |
Volltext (JSTOR) Volltext (kostenfrei) Volltext (kostenfrei) |
Summary: | Gebhardt draws attention to an important issue. The responsibility for informing and warning patients about adverse effects and how to prevent them, or … |
---|---|
ISSN: | 1473-4257 |
Contains: | Enthalten in: Journal of medical ethics
|
Persistent identifiers: | DOI: 10.1136/jme.28.4.277-a |